All treatments are administered by licensed medical professionals under physician oversight
Human data: caution The only human data published to date are extremely limited: a 2024 pilot trial in 12 patients with interstitial cystitis treated with 10 mg of BPC-157 injected into the bladder wall, and a 2026 pharmacokinetic study in two healthy subjects (one 58-year-old man and one 68-year-old woman) receiving intravenous BPC-157
Most clients report mild, temporary gastrointestinal symptoms, including slight nausea, indigestion, or mild constipation, which usually subside as their bodies adapt
Most people report a "glow" or an "evenness" in their skin before they notice a change in the actual shade
Saab, University of Zurich, Switzerland Updates Copyright 2020 Jha and Morrison
Int J Mol Sci 24(4):3207 Wang Y, Wu L, Fu J, Lv H, Guan X, Xu L, Chen P, Gao C, Hou P, Ji M (2013) Hyperthyroid monkeys: a nonhuman primate model of experimental Graves disease
